GSK PLC (GSK)
44.98
+0.10
(+0.22%)
USD |
NYSE |
May 17, 16:00
45.05
+0.07
(+0.16%)
Pre-Market: 05:44
GSK Net Income (TTM): 5.648B for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.648B |
| December 31, 2023 | 6.132B |
| September 30, 2023 | 7.456B |
| June 30, 2023 | 18.34B |
| March 31, 2023 | 17.36B |
| December 31, 2022 | 17.96B |
| September 30, 2022 | 16.50B |
| June 30, 2022 | 5.653B |
| March 31, 2022 | 6.549B |
| December 31, 2021 | 5.610B |
| September 30, 2021 | 6.208B |
| June 30, 2021 | 5.930B |
| March 31, 2021 | 6.786B |
| December 31, 2020 | 7.313B |
| September 30, 2020 | 8.093B |
| June 30, 2020 | 8.398B |
| March 31, 2020 | 6.831B |
| December 31, 2019 | 5.906B |
| September 30, 2019 | 5.796B |
| June 30, 2019 | 5.730B |
| March 31, 2019 | 5.093B |
| December 31, 2018 | 4.775B |
| September 30, 2018 | 2.486B |
| June 30, 2018 | 2.226B |
| March 31, 2018 | 1.395B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.927B |
| September 30, 2017 | 2.971B |
| June 30, 2017 | 2.446B |
| March 31, 2017 | 2.051B |
| December 31, 2016 | 1.159B |
| September 30, 2016 | 303.21M |
| June 30, 2016 | 75.54M |
| March 31, 2016 | 928.63M |
| December 31, 2015 | 12.79B |
| September 30, 2015 | 14.96B |
| June 30, 2015 | 14.79B |
| March 31, 2015 | 15.67B |
| December 31, 2014 | 4.510B |
| September 30, 2014 | 6.859B |
| June 30, 2014 | 7.692B |
| March 31, 2014 | 8.196B |
| December 31, 2013 | 8.584B |
| September 30, 2013 | 5.962B |
| June 30, 2013 | 6.204B |
| March 31, 2013 | 6.559B |
| December 31, 2012 | 7.120B |
| September 30, 2012 | 7.726B |
| June 30, 2012 | 8.200B |
| March 31, 2012 | 8.045B |
| December 31, 2011 | 8.433B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
5.610B
Minimum
Dec 2021
18.34B
Maximum
Jun 2023
8.710B
Average
6.668B
Median
Net Income (TTM) Benchmarks
| AstraZeneca PLC | 6.331B |
| Haleon PLC | 1.368B |
| Novo Nordisk A/S | 12.99B |
| Pfizer Inc | -309.00M |
| Sanofi SA | 4.947B |